selected publications
- Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates. Health affairs (Project Hope). 2024 Academic Article GET IT
- Trends in Integration Between Physician Organizations and Pharmacies for Self-Administered Drugs. JAMA network open. 2024 Academic Article GET IT
- Medicare price negotiation and pharmaceutical innovation following the Inflation Reduction Act. Nature biotechnology. 2024 Review GET IT
-
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies.
Journal of health politics, policy and law.
2022
Academic Article
GET IT
Times cited: 2 - Hospital Allocation and Racial Disparities in Health Care. The Review of Economics and Statistics. 2022 Academic Article GET IT
-
Mammographic Surveillance in Older Women With Breast Cancer in Canada and the United States: Are We Choosing Wisely?.
Practical radiation oncology.
2021
Academic Article
GET IT
Times cited: 1 - Randomized controlled study using text messages to help connect new medicaid beneficiaries to primary care. NPJ digital medicine. 2021 Academic Article GET IT
-
Allocation of COVID-19 Relief Funding to Disproportionately Black Counties.
JAMA.
2020
Letter
GET IT
Times cited: 30 -
Physician and facility drivers of spending variation in locoregional prostate cancer.
Cancer.
2020
Academic Article
GET IT
Times cited: 1 - Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S. 2020 Working Paper GET IT
-
Marketwide Price Transparency Suggests Significant Opportunities For Value-Based Purchasing.
Health affairs (Project Hope).
2019
Academic Article
GET IT
Times cited: 6 -
What drives variation in spending for breast cancer patients within geographic regions?.
Health services research.
2018
Academic Article
GET IT
Times cited: 5